Estradiol Patch — Systemic Estrogen Support Through Transdermal Delivery
A transdermal systemic estradiol option designed for individualized menopausal hormone therapy. Patch delivery bypasses first-pass hepatic metabolism and can be titrated to symptom burden, treatment goals, and tolerability.
Estradiol Patch
A systemic estrogen approach commonly used for vasomotor symptoms, sleep disruption, and other menopausal symptoms when estrogen replacement is clinically appropriate.
Uterine Protection
Women with an intact uterus generally require progesterone support or a levonorgestrel IUD when using systemic estradiol to reduce endometrial stimulation risk.
| Symptom Burden | Protocol | Frequency | Notes |
|---|---|---|---|
| Mild symptoms | 0.025 mg patch | Twice weekly | Often used as a low starting dose |
| Moderate symptoms | 0.05 mg patch | Twice weekly | Common mid-range starting option |
| Severe symptoms | 0.075 mg to 0.1 mg patch | Twice weekly | Titrate to symptom relief and tolerability |
Apply to a clean, dry area of the lower abdomen or upper buttock. Rotate sites and avoid placing on irritated skin or the breasts.
- Systemic estradiol is the most effective therapy for menopausal vasomotor symptoms when benefits outweigh risks.
- For women with a uterus, add progesterone support or confirm alternative endometrial protection.
- Reassess symptom control, bleeding pattern, side effects, blood pressure, and overall risk profile periodically.
- Patch therapy may be preferred when a transdermal route is desired to reduce hepatic first-pass exposure.
Estradiol replenishes declining estrogen signaling after menopause. Transdermal delivery provides systemic absorption through the skin, helping stabilize thermoregulatory signaling, support urogenital tissues, and address estrogen-deficiency symptoms.
- Supports vasomotor symptom control
- Provides systemic estrogen exposure
- Can help address menopause-related sleep disruption and quality-of-life symptoms
- Undiagnosed abnormal genital bleeding
- Known, suspected, or history of estrogen-dependent malignancy where estrogen is contraindicated
- Active or prior DVT, PE, stroke, MI, or known thrombophilic disorder
- Known liver disease or hypersensitivity to estradiol system components
- Evaluate any postmenopausal bleeding promptly
Common adverse effects: Breast tenderness, skin irritation at the application site, headache, nausea, bloating, or spotting may occur.
- Store at controlled room temperature unless otherwise directed by the labeled product or pharmacy instructions.
- Keep patches in the sealed protective pouch until ready to use.
- Avoid applying to broken or irritated skin.
- The medicine should be fine for 5 days from the shipping date at temperatures up to 105 degrees Fahrenheit.
Where should I place the patch?
Apply it to clean, dry skin on the lower abdomen or upper buttock, rotating sites as directed.
Do I need progesterone with this?
If you still have a uterus, systemic estradiol generally requires progesterone support or alternative endometrial protection.
When should I feel improvement?
Many patients notice improvement in vasomotor symptoms over the first several weeks, but titration may be needed.
Partner with Genesis Compounding
A 503A-licensed compounding partner built for telehealth and physician practice workflows. Download your onboarding documents below to get started.
Fax completed forms to 385-855-1221 or email pharmacy@genesiscompounding.com